Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Prostate Cancer Recurrent × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 17 Neoplasms 13 Prostatic Neoplasms 11 Neoplasm Metastasis 10 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Polycystic Ovary Syndrome 7 Pain 7 Lung Neoplasms 7 Leiomyoma 6 Anemia 5 Skin Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia 4 Carcinoma, Renal Cell 4 Recurrence 3 Melanoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Keratosis, Actinic 3 Insulin Resistance 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Sleep Initiation and Maintenance Disorders 2

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01512472 2019-09-23

FIT

Canadian Urology Research Consortium

Phase 4 Terminated

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡